These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35810257)

  • 1. LncRNA H19 is a potential biomarker and correlated with immune infiltration in thyroid carcinoma.
    Sahin Y
    Clin Exp Med; 2023 Jul; 23(3):841-851. PubMed ID: 35810257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of m6A-associated LncRNAs as predict factors for the immune infiltration and prognosis of thyroid cancer.
    Su Y; Xu B; Li J; Shen Q; Lei Z; Ma M; Zhang F; Hu T
    Ann Med; 2023 Dec; 55(1):1298-1316. PubMed ID: 36974635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated PDE4C level serves as a candidate diagnostic biomarker and correlates with poor survival in thyroid carcinoma.
    Wang Y; Zhang Y; Li Y; Huang J
    Sci Rep; 2024 Mar; 14(1):6813. PubMed ID: 38514754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of disulfidptosis-associated genes and characterization of immune cell infiltration in thyroid carcinoma.
    Song S; Zhou J; Zhang L; Sun Y; Zhang Q; Tan Y; Zhou X; Yu J
    Aging (Albany NY); 2024 Jun; 16(11):9753-9783. PubMed ID: 38836761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of prognostic biomarkers related to the tumor microenvironment in thyroid carcinoma.
    Du JW; Li GQ; Li YS; Qiu XG
    Sci Rep; 2021 Aug; 11(1):16239. PubMed ID: 34376710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics analysis for the identification of Sprouty-related EVH1 domain-containing protein 3 expression and its clinical significance in thyroid carcinoma.
    Zhang X; Meng X; Wang P; Luan C; Wang H
    Sci Rep; 2024 Feb; 14(1):4549. PubMed ID: 38402263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma.
    Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J
    Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
    Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
    Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCND1 as a Prognostic and Diagnostic Biomarker and the Impact of Its Epigenetic Alterations on Cancer Survival.
    Taha MY; Mohamed NO; Alhaj LG; Altayeb I; Basheer A; Idrees S; Said AM; Alfaki M
    Cureus; 2024 Jul; 16(7):e65504. PubMed ID: 39188436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and Validation of an Immune-Related lncRNA Prognosis Model for Thyroid Cancer.
    Li Z; Wang H; Deng X; Zhang J; Wang L; Tang W; You W; Nian W
    Comb Chem High Throughput Screen; 2022; 25(13):2217-2227. PubMed ID: 35209814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of potential LncRNAs as papillary thyroid carcinoma biomarkers based on integrated bioinformatics analysis using TCGA and RNA sequencing data.
    Feng JL; Zheng WJ; Xu L; Zhou QY; Chen J
    Sci Rep; 2023 Mar; 13(1):4350. PubMed ID: 36928327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.
    Pang R; Yang S
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased FGF2 expression promotes immune cell infiltration and correlates with an unfavorable prognosis in thyroid cancer.
    Chen H; Du X
    Heliyon; 2024 Jun; 10(11):e32272. PubMed ID: 38873667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of non-coding RNA related prognosis biomarkers based on ceRNA network in thyroid cancer.
    Fang X; Chen X; Gao J; Tong L
    Front Genet; 2023; 14():1157438. PubMed ID: 37153003
    [No Abstract]   [Full Text] [Related]  

  • 16. HSPA5 is a prognostic biomarker correlated with immune infiltrates in thyroid carcinoma.
    Dong W; Du D; Huang H
    Endokrynol Pol; 2022; 73(4):680-689. PubMed ID: 36059163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of BTNL9 as a prognostic biomarker correlated with immune infiltrations in thyroid cancer.
    Zhang L; Yu S; Hong S; Xiao X; Liao Z; Li Y; Xiao H
    BMC Med Genomics; 2023 Oct; 16(1):234. PubMed ID: 37798795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic analysis of the prognosis and immune infiltration of E2Fs in thyroid carcinoma.
    Fu X; Zhou X; Ji F; He Q; Qiu X
    Front Genet; 2023; 14():1215984. PubMed ID: 37560385
    [No Abstract]   [Full Text] [Related]  

  • 19. The prognostic value of plasma complement factor B (CFB) in thyroid carcinoma.
    Wu P; Shi J; Sun W; Zhang H
    Bioengineered; 2021 Dec; 12(2):12854-12866. PubMed ID: 34898340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prognostic Value of PERK in Cancer and Its Relationship With Immune Cell Infiltration.
    Wang P; Han L; Yu M; Cao Z; Li X; Shao Y; Zhu G
    Front Mol Biosci; 2021; 8():648752. PubMed ID: 33937330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.